Document is current

Article History

Received: 6 April 2018

Accepted: 10 September 2018

First Online: 8 November 2018

Ethics approval and consent to participate

: Our study involved human data. We obtained approval from UTMB’s IRB Committee. The IRB number is 14-0350. We had a corresponding consent form, explaining the purpose of this research study, procedures to be followed, and risks and benefits to the study participants. Additionally, study participants were informed of how their information will be stored and how their privacy will be protected. Any additional questions and concerns were answered and addressed.

: We had a UTMB Minimal Risk Consent Form with our protocol title and IRB number. Within the consent form, the purpose of this research study, procedures to be followed, and risks and benefits were explained to the study participants. We received consent from the all of the patients whose data was gathered, resulting in a total of six consent forms.

: AL is the Chairman of the Clinical Advisory Board for ClearLine MD.The remaining authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.